title: A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements.
abstract: BACKGROUND
  Accurate and precise measurement of blood cholesterol plays a central role in the National Cholesterol Education Program's strategy to reduce the morbidity and mortality attributable to coronary heart disease. Matrix effects hamper the ability of manufacturers to adequately calibrate and validate traceability to the National Reference System for Cholesterol (NRS/CHOL). CDC created the Cholesterol Reference Method Laboratory Network (CRMLN) to improve cholesterol measurement by assisting manufacturers of in vitro diagnostic products with validation of the traceability of their assays to the NRS/CHOL.
  
  
  METHODS
  CRMLN laboratories established the CDC cholesterol reference method (modification of the Abell-Levy-Brodie-Kendall chemical method) and are standardized using CDC frozen serum reference materials. CRMLN laboratories use common quality-control materials and participate in monthly external performance evaluations conducted by CDC. The CRMLN performance criteria require member laboratories to agree with CDC within +/-1.0% and maintain a CV < or =2.0%.
  
  
  RESULTS
  From 1995 to 200 the CRMLN laboratories met the accuracy criterion 97% of the time and the precision criterion 99% of the time. During this time period, the CRMLN maintained an average bias to CDC of 0.01% and an average collective CV of 0.33%.
  
  
  CONCLUSIONS
  CDC established the CRMLN as the first international reference method laboratory network. The CRMLN assists manufacturers in the validation of the calibration of their diagnostic products so that clinical laboratories can measure blood cholesterol more reliably. The CRMLN can serve as a model for other clinical analytes where traceability to a hierarchy of methods is needed and matrix effects of the field methods with processed calibrators or reference materials are present.
authors.affiliation: Centers for Disease Control and Prevention, 4770 Buford Hwy NE (F25), Atlanta, GA 30341, USA. glm1@cdc.gov
authors.forename: G L
authors.initials: GL
authors.lastname: Myers
authors.forename: M M
authors.initials: MM
authors.lastname: Kimberly
authors.forename: P P
authors.initials: PP
authors.lastname: Waymack
authors.forename: S J
authors.initials: SJ
authors.lastname: Smith
authors.forename: G R
authors.initials: GR
authors.lastname: Cooper
authors.forename: E J
authors.initials: EJ
authors.lastname: Sampson
mesh_terms: D002138:Calibration; D002624:Chemistry, Clinical / Q000592:standards*; D002784:Cholesterol / Q000097:blood / Q000592:standards*; D003627:Data Interpretation, Statistical; D006801:Humans; D007753:Laboratories / Q000592:standards*; D011786:Quality Control; D012015:Reference Standards; D015203:Reproducibility of Results
chemical_list: D002784:Cholesterol